BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $8

Benzinga Newsdesk www.benzinga.com Positive 71.9%

Neg 0% Neu 0% Pos 71.9%

BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $7 to $8.

Comments

No comments yet. Be the first!